PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12547825-3	2003	We report here that 17-epiestriol, an estrogen metabolite and a selective estrogen receptor (ER) beta agonist, is approximately 400x more potent than 17-beta E(2) in suppressing tumor necrosis factor (TNF) alpha-induced VCAM-1 mRNA as well as protein expression in human umbilical vein endothelial cells.	17-Epiestriol	20-33	estrogen receptor 2	Homo sapiens	74-101	
15878629-4	2005	By comparison, 17-epiestriol, an estrogen receptor beta (ERbeta) agonist and 17-beta-E2, an ER agonist that is almost equally potent for ERalpha and ERbeta were less effective in stimulating RAGE expression.	17-Epiestriol	15-28	estrogen receptor 2	Homo sapiens	33-55	
15878629-4	2005	By comparison, 17-epiestriol, an estrogen receptor beta (ERbeta) agonist and 17-beta-E2, an ER agonist that is almost equally potent for ERalpha and ERbeta were less effective in stimulating RAGE expression.	17-Epiestriol	15-28	estrogen receptor 2	Homo sapiens	57-63	
11078914-3	2000	Combinations of ERbeta ligands such as estradiol (E(2)), 17 epiestriol (17E(3)), quercetin (Q) with tamoxifen (TMX) showed marked growth inhibition.	17-Epiestriol	57-70	estrogen receptor 2	Homo sapiens	16-22